Clinical Trials
19
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
The TARGET BP OFF-MED Trial
- Conditions
- Hypertension,EssentialHypertension
- Interventions
- Other: Sham control
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Ablative Solutions, Inc.
- Target Recruit Count
- 350
- Registration Number
- NCT03503773
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Brussels, Belgium
🇫🇷Clinique Pasteur Toulouse, Toulouse, France
🇩🇪Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
TARGET BP I Clinical Trial
- Conditions
- Hypertension
- Interventions
- Device: Peregrine System Kit (Sham Procedure)
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Ablative Solutions, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT02910414
- Locations
- 🇺🇸
Cardiology PC, Birmingham, Alabama, United States
🇺🇸Piedmont Heart Institute, Atlanta, Georgia, United States
🇺🇸NC Heart and Vascular Research, Raleigh, North Carolina, United States
The Peregrine Post-Market Study for the Treatment of Hypertension
- Conditions
- Hypertension
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Ablative Solutions, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT02570113
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Brussels, Belgium
🇨🇿Na Homolce Hospital, Prague, Czechia
🇩🇪Charite-Universitaetsmedizin Berlin, Berlin, Germany
The Peregrine Study: A Safety and Performance Study of Renal Denervation
- Conditions
- Hypertension
- First Posted Date
- 2014-06-04
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Ablative Solutions, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02155790
- Locations
- 🇨🇿
Na Homolce Hospital, Prague, Czechia
🇵🇱American Heart of Poland, Ustron, Poland